Literature DB >> 23961607

[Biliary atresia].

Hanna Lampela1, Mikko Pakarinen.   

Abstract

Biliary atresia is a rare, neonatal, progressive cholestatic liver disease caused by fibroinflammatory obstruction of the biliary tree. Typical symptoms include prolonged neonatal jaundice, pale stools, and conjugated hyperbilirubinemia. Treatment starts with portoenterostomy, where fibrotic remnants of the extra hepatic bile ducts are replaced with small intestine. Best operative results are achieved among the youngest patients treated in specialized centres. Despite clearance of jaundice after a successful operation, fibrotic change of the liver continues in most. Liver transplantation serves as a salvage procedure if the portoenterostomy fails, or complications of liver cirrhosis develop after an initially successful portoenterostomy. In Finland, biliary atresia treatment was centralized in 2005. Of the patients treated thereafter, 90% are alive and over 80% with their native livers.

Entities:  

Mesh:

Year:  2013        PMID: 23961607

Source DB:  PubMed          Journal:  Duodecim        ISSN: 0012-7183


  3 in total

1.  Gene expression profiling of extrahepatic ducts in children with biliary atresia.

Authors:  Jiang Wang; Wei Wang; Rui Dong; Rui Zhao; Zhu Jin; Wenjun Shen; Shan Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  Single nucleotide polymorphisms within Adducin 3 and Adducin 3 antisense RNA1 genes are associated with biliary atresia in Thai infants.

Authors:  Wison Laochareonsuk; Piyawan Chiengkriwate; Surasak Sangkhathat
Journal:  Pediatr Surg Int       Date:  2018-03-05       Impact factor: 1.827

3.  Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia.

Authors:  Yongqin Ye; Weifang Wu; Jiachen Zheng; Lihui Zhang; Bin Wang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.